You are here

Minkowski Prize

Prize awarded for research contributing to the advancement of knowledge concerning diabetes mellitus.

The Minkowski Prize will be given in relation to research which has been carried out by an outstanding researcher normally residing in Europe. It is awarded for distinction manifested by publications which contribute to the advancement of knowledge concerning diabetes.

  • Candidates must be an EASD Member and
  • Candidates should be resident in Europe and
  • Candidates should be younger than 45yrs in the year of nomination and/or
  • their MD or PhD degree should have been obtained within the last 15 years
  • Board Members of EASD are not eligible for nomination

Time periods (up to two years) spent on maternity/paternity leave, in part-time employment, long-term illness or other exceptional circumstances will be taken into account, if adequate documentation is provided.

Nominations must be made on the available nomination form and sent as one complete pdf via email, containing:

  • the most relevant publications (not more than ten)
  • a statement in English by the proposer(s) explaining the manner in which the candidate's published contributions have aided knowledge concerning diabetes. Such a statement must not exceed 1,000 words
  • the candidate's curriculum vitae

The recipient is expected to give a lecture at the Annual Meeting in the year of the award describing his/her most important scientific achievements.

The Minkowski Prize is generously supported by Lilly.

Minkowski Awardees:

2023 Hamburg
T. Müller (DE): Novel insights into regulation of energy and glucose metabolism by GIP and GIPR:GLP-1R co-agonists

2022 Stockholm
M. Heni (DE): The insulin resistant brain: impact on whole-body metabolism and body fat distribution

2021 Virtual Meeting
A. Bonnefond (FR): Hunt for rare variants and pretty little things in the genetics of diabetes

2020 Virtual Meeting
G.P. Fadini (IT): Should I stay or should I go? The bone marrow and stem cell traffic in diabetes

2019 Barcelona
F.K. Knop (DK): My gut feeling about glucagon

2018 Berlin
F. Bäckhed (SE): The gut microbiota - a forgotten organ - that contributes to glucose metabolism

2017 Lisbon
E.R. Pearson (UK): Targeting therapy in diabetes: insights from genetics

2016 Munich
P. Schrauwen (NL):
Let's energise: mitochondria and energy turnover to comBAT type 2 diabetes

2015 Stockholm
M. Blüher (DE):
Size, sites and cytes: importance of adipose tissue in diabetes and beyond

2014 Vienna
A. Gloyn (UK):
Unravelling causal mechanisms in diabetes pathogenesis

2013 Barcelona
M. Cnop (BE):
The heart of the matter: beta cells in diabetes

2012 Berlin
T.M. Frayling (UK):
Human genetics and type 2 diabetes: behind the headlines

2011 Lisbon
N. Sattar (UK):
Exploiting biomarkers and large datasets for insights into diabetes and cardiovascular disease

2010 Stockholm
F. Gribble (UK):
Molecular mechanisms underlying the secretion of incretin hormones

2009 Vienna
G. Perseghin (IT):
Ectopic fat: the result of the interaction between insulin resistance and energy metabolism

2008 Rome
J.C. Brüning (DE):
Insulin action in the central nervous system: from metabolism to neurodegeneration and control of lifespan

2007 Amsterdam
M. Stoffel (CH):
Transcriptional control of metabolism in type 2 diabetes: Lessons learned from fasting and feeding

2006 Copenhagen
M. Roden (DE):
From overabundance to energy crisis

2005 Athens
P. Rossing (DK):
Progression of diabetic nephropathy: Prediction, promotion, prevention - and the pill

2004 Munich
G.A. Rutter (UK):
Orchestrating insulin secretion at the single vesicle level

2003 Paris
M. Stumvoll (DE):
Control of glycemia - from molecules to men

2002 Budapest
B.O. Roep (NL):
T-cells in the pathogenesis of type 1 diabetes: The good, the bad and the ugly

2001 Glasgow
J.R. Zierath (SE):
Insulin signalling and glucose transport in sketal muscle: Unravelling the mysteries of metabolic disease

2000 Jerusalem
H. Edlund (SE):
Factors controlling beta-cell identity and glucose homeostasis

1999 Brussels
R. Scharfmann (FR):
Control of early development of the pancreas in rodent and human

1998 Barcelona
J.H. Auwerx (FR):
PPARγ, a versatile metabolic regulator

1997 Helsinki
P. Froguel (FR):
Genetics of type 2 diabetes: Back to the future

1996 Vienna
P. Rorsman (DK):
The pancreatic beta-cell as a fuel sensor: An electrophysiologist's view point

1995 Stockholm
J. Todd (UK):
The genetics of type I diabetes: It was only a nightmare

1994 Düsseldorf
T. Mandrup Poulson (DK):
The role of interleukin-1 in the pathogenesis of insulin dependent diabetes dellitus

1993 Istanbul
H. Yki-Järvinen (FI):
Insulin action in heart, muscle and liver - from pathophysiology towards optimal therapy

1992 Prague
E. van Schaftingen (BE):
Glycolysis revisited

1991 Dublin
C. Boitard (FR):
The differentiation of the immune system towards anti-islet immunity. Clinical prospects

1990 Copenhagen
P. Halban (CH):
Proinsulin trafficking and processing

1989 Lisbon
H.-U. Häring (DE):
The insulin receptor kinase: Its role in insulin action and in the pathogenesis of type 2 (non-insulin-dependent) diabetes

1988 Paris
J.C. Hutton (UK):
The insulin secretory Granule

1987 Leipzig
J.-L. Carpentier (CH):
The cell biology of the insulin receptor interaction

1986 Rome
D. Pipeleers (BE):
Biosociology of the pancreatic beta-cell

1985 Madrid
E. Van Obberghen (FR):
Insulin receptor: from hormone recognition to cell activation

1984 London
A. Lernmark (DK):
Molecular biology of insulin dependant diabetes

1983 Oslo
S.L. Howell (UK):
The mechanism of insulin secretion

1982 Budapest
G.F. Bottazzo (UK):
B-cell damage: Are we approaching the solution?

1981 Amsterdam
P. De Meyts (BE):
The multiple affinity States of the insulin receptor and their physiological implication

1980 Athens
I.-B. Taljedal (SE):
On insulin secretion

1979 Vienna
S.J. Ashcroft (UK):
Glucoreceptor mechanisms and the control of insulin release and biosynthesis

1978 Zagreb
J. Nerup (DK):
HLA factors and autoimmunity in insulin-dependant diabetics

1977 Geneva
J. Wahren (SE):
Physical exercise and fuel homeostasis in diabetes mellitus

1976 Helsinki
K.D. Hepp (DE):
Studies on the mechanism of insulin action: Basic concepts and clinical implications

1975 Munich
P. Freychet (FR):
Interactions of polypeptide hormones with cell membrane specific receptors: Studies with insulin and glucagon

1974 Jerusalem
E. Cerasi (SE):
Mechanisms of glucose stimulated insulin secretion in health and in diabetes: Some re-evaluations and proposals

1973 Brussels
L. Orci (IT/CH):
A portrait of the pancreatic beta-cell

1972 Madrid
W.J. Malaisse (BE):
Insulin secretion: multifactorial regulation for a single process of release

1971 Southampton
C.N. Hales (UK):
Immunological techniques in diabetes research

1970 Warsaw
B. Jeanrenaud (CH):
Adipocytes, available energy and endocrine pancreas

1969 Montpellier
B. Hellman (SE):
Methodological approaches to studies on the pancreatic islets

1968 Louvain
L.A. Carlson (SE): Antilipolysis as a tool in the study of clinical and experimental diabetes

1967 Stockholm
E.R. Froesch (CH): The physiology and pharmacology of adipose tissue lipolysis: Its inhibition and implications for the treatment of diabetes

1966 Aarhus
P.J. Randle (UK): Carbohydrate metabolism and lipid storage and break-down in diabetes